The space agencies are actively engaged in studying the physiological adaptation to space environment through studies on board the International Space Station (ISS) but also on the ground. Different methods are used to simulate weightlessness on Earth, including cellular models, animal models using hind-limb unloading, or on humans with unilateral lower limb suspension. However, two approaches, -6° head-down bed rest (HDBR) and dry immersion (DI) have provided possibilities for long-term exposures with findings closest to those seen with a weightless state. They produce changes in body composition (including body fluid redistribution), cardiovascular and skeletal muscle characteristics that resemble the effects of microgravity. The common physiological denominator is the combination of a cephalad shift of body fluids and reduced physical activity. Being similar in their effects on the human body, these models, however, differ in their specifics and acting factors. The Head-down Bedrest (HDBR) model has been widely used for this purpose and is considered one of the references for reproducing the physiological effects of weightlessness on Earth. During HDBR, subjects are lying down with an angle of -6° between the feet and head, on their side, their back or their front, but must keep one shoulder in contact with the mattress. All daily activities and tests are performed in this position. One of the advantages of the HDBR model is that it has now been used in a great number of studies internationally, and its effects have long been described and compared with those of microgravity and spaceflight. Long-term bedrest is the gold-standard method for studying the effects of weightlessness and to test countermeasures. Dry immersion involves immersing the subject in water covered with an elastic waterproof fabric. As a result, the immersed subject, who is freely suspended in the water mass, remains dry. Within a relatively short duration, the model can faithfully reproduce most physiological effects of actual microgravity, including centralization of body fluids, support unloading, and hypokinesia. The objective of the present study is to compare the physiological adaptations to10 days of dry immersion versus 10 days of head-down bedrest in 20 healthy male subjects. A set of measurements will assess the changes in the cardiovascular, neuro-ophthalmological, hematological, metabolic, sensorimotor, immune, muscle and bone systems as a result of both models. The most likely outcome of this study will not be to show a clear superiority of one model over the other. Rather, we expect to show differences in kinetics and intensity of adaptations, that should vary from one system to another. This will help future researchers choose the best model depending on the system they are investigating and the rapidity or intensity of the effect they are exploring. The two models, instead of competing with one another, are probably complementary.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Changes in orthostatic tolerance
Timeframe: At baseline and first day of recovery
Changes in peak aerobic power (VO2max test)
Timeframe: At baseline and the first day of recovery
Change in plasma volume
Timeframe: At baseline and 3 days after the end of the intervention
Change in plasma volume percentage
Timeframe: At baseline and at day 1, day 3, day 7 and at the end of the intervention periods
Change in fluid shift distribution towards the cardiac and cephalic region
Timeframe: At baseline, the first day to quantify the short term effect, the fifth day and the tenth day of interventions to quantify the long term effect of fluid shift
Change in body fluid compartments by bioelectrical impedance analysis
Timeframe: At baseline, during the ten days of intervention and until 3 days after the end of the intervention
Change in calf and thigh circumferences
Timeframe: At baseline, during the intervention period and until 3 days after the intervention period
Change in fat and lean body mass measured by dual energy x-ray absorptiometry (DEXA)
Timeframe: At baseline, after 10 days of dry-immersion and 10 days of reovery
Change in Resting Metabolic Rate (RMR)
Timeframe: At baseline, at day 3 and day 9 days of intervention periods
Change in nitrogen balance
Timeframe: At baseline, at day 3 and day 9 days of intervention periods
Change in glucose tolerance (Oral Glucose Tolerance Test)
Timeframe: At baseline, at day 3 and day 9 days of intervention periods
Change in serum bone formation marker (bone-specific Alkaline Phosphatase bAP)
Timeframe: At baseline and during the 10 days of interventions
Change in serum bone resorption marker (C-terminal cross-linked telopeptide of type I collagen CTx)
Timeframe: At baseline and during the 10 days of interventions
Changes in bone density (by DEXA and High Resolution Peripheral Computed Tomography (HR-pQCT))
Timeframe: At baseline and at day 10 of intervention periods
Change in serum cartilage synthesis biomarkers
Timeframe: At baseline, during the intervention period and until 3 days after the intervention period
Change in serum cartilage degradation biomarkers
Timeframe: At baseline, during the intervention period and until 3 days after the intervention period
Change in muscle strength
Timeframe: At baseline and after one day of recovery
Changes in jump performance
Timeframe: At baseline and the first day of recovery
Change in contraction time
Timeframe: At baseline and at the end of the intervention periods
Change in standing balance
Timeframe: At baseline and at day 1 and day 2 of recovery
Change in walking balance
Timeframe: At baseline and after 10 days of intervention and day 1 after the end of the intervention
Change in height
Timeframe: At baseline and at day 1, day 2 and day 3 of recovery
Change in mid cerebral artery (MCA) blow flow velocity
Timeframe: At baseline and one day after the intervention period
Change in circadian rhythms of blood pressure
Timeframe: At baseline and during the ten days of the intervention periods
Change in mood
Timeframe: At baseline, at day 5 of the intervention period and 3 days after the end of the intervention
Change in affective states
Timeframe: At baseline, at day 5 of the intervention period and 3 days after the end of the intervention
Change in sleep quality
Timeframe: Daily from baseline to 10 days after the end of the intervention
Change in psychological state: mental health
Timeframe: At baseline, at day 5 of the intervention period and 4 days after the end of the intervention
Change in coping strategies
Timeframe: At day 5 of the intervention and 2 days after the end of the intervention
Measurement of changes in subjective sleepiness
Timeframe: At baseline, at day 4 and 8 of the intervention period and 3 days after the end of the intervention
Change in circadian variations of heart rate
Timeframe: At baseline, at day 1, day 4, day 7 of intervention, and at first day of recovery
Change in daily body movements
Timeframe: Continuously from baseline until 5 days after the intervention period
Dynamics of body fluids during the 4 first hours of exposure
Timeframe: The 4 first hours of Dry Immersion / Bed Rest
Lower limb vascular properties
Timeframe: At baseline, at day 10 of intervention periods, and day 3 of recovery
Myofiber atrophy
Timeframe: At baseline and at day 8 of intervention
Post-occlusive reactive hyperemia at great toe and thumb level
Timeframe: At baseline and 4 days after the end of the intervention
Quantitative sensory testing at the dorsum of the foot (vibration detection threshold)
Timeframe: At baseline, at day 7 of intervention periods, and day 2 of recovery
Whole-body MRI
Timeframe: At baseline, at day 9 of intervention periods
Vestibular health evaluation
Timeframe: At baseline and the first day of recovery
Blood cytokines evolution
Timeframe: At baseline, at day 3 & 10 of intervention periods, and day +10 of recovery
Salivary cortisol evolution
Timeframe: At baseline, at day 1, 3 & 10 of intervention periods, and day +4 & +10 of recovery
Change in optic nerve sheath diameter (ONSD) considered as an indirect marker for intracranial pressure (ICP) estimation
Timeframe: From baseline to 1 day after the end of the intervention
Change in intraocular pressure (IOP)
Timeframe: From baseline to 1 day after the end of the intervention
Change in visual acuity
Timeframe: At baseline and 2 days after the intervention period
Change in visual field
Timeframe: At baseline and 2 days after the intervention period
Change in the anatomical characteristics of the eye (optical biometry)
Timeframe: At baseline and 2 days after the intervention period
Change in the central corneal thickness
Timeframe: At baseline and 2 days after the intervention period
Change in the retina by non-mydriatic fundus retinography
Timeframe: At baseline and 2 days after the intervention period
Change in the cornea topography
Timeframe: At baseline and 2 days after the intervention period
Change in cerebral structures and in venous circulation of the brain by MRI
Timeframe: At baseline and at day 9 of intervention
Change in thrombotic and fibrinolytic processes
Timeframe: At baseline, during the intervention and 2 days after the intervention period
Change in energy requirements
Timeframe: At baseline and at day 2 of the intervention period
Change in skin microcirculation
Timeframe: At baseline and 3 days after the intervention period
Change in cardiovascular deconditioning and orthostatic tolerance (stand test)
Timeframe: At baseline and 2 days after the intervention period
Change in stress and mental load
Timeframe: From baseline to 10 days after the end of the intervention